UCB extends RCF to back of debt queue
UCB, the Belgian pharmaceutical company, has amended and extended its €1bn revolving credit facility early, pushing the maturity of its only commercial bank loan to the far end of its debt profile.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: